Mixed Results Announced for Trehalose in ALS Study
Topline data were announced from the phase 2/3 HEALEY ALS Platform trial evaluating SLS-005 for amyotrophic lateral sclerosis (ALS).
Stay updated with breaking news from Transcription Factor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Topline data were announced from the phase 2/3 HEALEY ALS Platform trial evaluating SLS-005 for amyotrophic lateral sclerosis (ALS).
In a new study, decreased plasma EGR1 protein levels and patients with fibromyalgia had a statistically significant relationship.
Like thieves that constantly look for ways to evade capture, Salmonella enterica, a disease-causing bacterium, uses various tactics to escape the human body's defence mechanisms.
- The Expanded Access Program is funded by a grant from the National Institute of Neurological Disorders and Stroke under the Accelerating Access to Critical Therapies for ALS for ALS patients who... | April 4, 2023
Humoral immune response is important in fighting pathogens by the production of specific antibodies by B cells. In germinal centers, T follicular helper (TFH) cells provide important help to B-cell antibody production but also contribute to HIV persistence. T follicular regulatory (TFR) cells, which inhibit the function of TFH cells, express similar surface markers. Since FOXP3 is the only marker that distinguishes TFR from TFH cells it is unknown whether the increase in TFH cells observed in HIV infection and HIV persistence may be partly due to an increase in TFR cells. Using multicolor flow...